Nephron Pharmaceuticals is a women-owned manufacturer of generic respiratory inhalation solutions that proudly offers Racepinephrine 2.25%, Albuterol Sulfate 0.5%, 0.083%, 0.042%, and 0.021%, Ipratropium Bromide & Albuterol Sulfate (Generic DuoNeb®), Ipratropium Bromide 0.02%, and Sodium Chloride USP, 0.9%. Nephron was the first company to individually wrap and bar-code unit dose medications for patient safety. Nephron proudly manufactures all of our products in the USA.
Location: United States, South Carolina, West Columbia
Member count: 501-1000
Phone: +1 800-443-4313
Total raised: $75M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | Backcast P... | backcastpa... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.08.2014 | - | $75M | - | medcitynew... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 25.10.2022 | Nephron SC... | Delivery Method: VIA Electroni... | - | - | einpresswi... |
| 31.03.2021 | ISPE Found... | Over the coming years, a diver... | - | - | prweb.com/... |
| 22.08.2014 | Generic dr... | Promoted Clinical Care Capaci... | - | - | medcitynew... |
| - | Generic dr... | Nephron Pharmaceuticals, a mak... | - | - | medcitynew... |